ASPI
ASP Isotopes Inc. Common Stock NASDAQ Listed Nov 10, 2022$3.18
Pre-mkt
$3.20
+0.50%
Mkt Cap $400.4M
52w Low $3.04
1.3% of range
52w High $14.49
50d MA $3.94
200d MA $5.40
P/E (TTM)
—
EV/EBITDA
—
P/B
1.0x
Debt/Equity
1.1x
ROE
-78.3%
P/FCF
-5.6x
RSI (14)
31.20
ATR (14)
$0.23
Beta
3.61
50d MA
$3.94
200d MA
$5.40
Avg Volume
3.7M
ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.
433 Plaza Real · Washington, FL 33432 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | AMC | -0.17 | -0.28 | -64.7% | 4.27 | +2.3% | -5.9% | -4.0% | +6.0% | -3.4% | +1.3% | — |
| May 20, 2026 | AMC | -0.06 | -0.06 | +0.0% | 5.26 | +0.0% | -1.7% | +7.4% | +24.9% | -3.8% | +16.5% | — |
| Apr 10, 2026 | AMC | -0.10 | -0.84 | -740.0% | 4.48 | +2.2% | +12.9% | -1.2% | +7.6% | -5.0% | +5.1% | — |
| Nov 19, 2025 | AMC | -0.15 | -0.15 | +0.0% | 7.50 | +4.4% | -11.3% | -10.2% | +3.4% | -2.9% | -1.2% | — |
| Aug 14, 2025 | AMC | -1.03 | -1.03 | +0.0% | 10.57 | +2.9% | -11.9% | -0.1% | -4.5% | +1.0% | +0.7% | — |
| May 20, 2025 | AMC | -0.12 | -0.12 | +0.0% | 7.00 | +1.4% | +10.9% | +0.5% | +10.1% | -7.1% | -2.5% | — |
| Apr 9, 2025 | AMC | -0.09 | -0.09 | +0.0% | 4.99 | -3.8% | +9.0% | +10.1% | +9.0% | -12.3% | -0.7% | — |
| Mar 31, 2025 | AMC | -0.09 | -0.13 | -44.4% | 4.69 | +0.2% | +2.8% | +7.1% | -5.2% | -9.8% | +3.6% | — |
| Nov 19, 2024 | AMC | -0.09 | -0.12 | -33.3% | 7.25 | -1.2% | -1.4% | +7.8% | +8.2% | -8.3% | -23.5% | — |
| Aug 19, 2024 | AMC | — | -0.24 | — | 2.05 | +3.4% | -1.0% | +16.3% | +1.7% | +7.1% | -0.8% | — |
| May 15, 2024 | AMC | — | -0.16 | — | 4.31 | +2.1% | +2.6% | +2.3% | +15.7% | +2.3% | -4.9% | — |
| Mar 29, 2024 | AMC | — | -0.05 | — | — | — | — | — | — | — | — | — |
| Nov 14, 2023 | AMC | — | -0.13 | — | 1.52 | +2.0% | +11.8% | +0.0% | +1.2% | -7.6% | +3.8% | — |
| Aug 14, 2023 | AMC | — | -0.14 | — | 1.34 | +0.0% | -0.7% | -8.3% | -2.9% | -11.4% | +8.6% | — |
| May 19, 2023 | AMC | — | -0.12 | — | 0.34 | -1.9% | +12.0% | -0.7% | -2.0% | -9.9% | -0.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 14 | Canaccord Genuity | Maintains | Buy → Buy | — | $5.06 | $5.19 | +2.6% | -1.2% | +7.6% | -5.0% | +5.1% | +1.9% |
| Nov 24 | Canaccord Genuity | Maintains | Buy → Buy | — | $5.97 | $6.16 | +3.2% | +3.4% | -2.9% | -1.2% | +5.1% | -10.3% |
| Sep 17 | Canaccord Genuity | Maintains | Buy → Buy | — | $8.97 | $8.91 | -0.7% | -2.5% | +4.3% | +8.0% | +13.8% | +2.0% |
| May 21 | Canaccord Genuity | Maintains | Buy → Buy | — | $7.00 | $7.10 | +1.4% | +10.9% | +0.5% | +10.1% | -7.1% | -2.5% |
| Oct 18 | Canaccord Genuity | Maintains | Buy → Buy | — | $4.04 | $4.21 | +4.2% | +5.9% | +13.1% | -1.9% | +4.0% | +5.9% |
| Aug 7 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.26 | $2.32 | +2.7% | -7.1% | +2.9% | -5.6% | -0.5% | +3.9% |
| Apr 17 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.16 | $3.40 | +7.6% | -3.8% | +1.6% | +0.3% | +1.0% | +2.2% |
| Feb 29 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.19 | $3.37 | +5.6% | +19.4% | +0.8% | -10.2% | -2.6% | +6.5% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Ainscow Robert | COO | Sell | 8,438 | $4.29 | $36K | 2,248,441 | -7.80% | +3.02% |
| Jul 1, 2026 | Kiessling Heather | Chief Financial Officer | Sell | 23,124 | $6.28 | $145K | 1,526,252 | -1.78% | -2.72% |
| Jun 30, 2026 | Ainscow Donald George | EVP, Gen Counsel, Secretary | Sell | 100,000 | $6.14 | $614K | 800,000 | -1.78% | -2.72% |
| Jun 30, 2026 | Gorley Michael | — | Sell | 30,000 | $6.27 | $188K | 87,908 | -8.75% | +4.15% |
| Jun 30, 2026 | Wider Todd | — | Sell | 50,000 | $6.12 | $306K | 672,247 | -8.75% | +4.15% |
| Jun 29, 2026 | Wider Todd | — | Sell | 50,000 | $6.25 | $312K | 722,247 | -8.75% | +4.15% |
| Jun 8, 2026 | Ainscow Robert | COO | Sell | 8,438 | $7.00 | $59K | 2,281,879 | +6.50% | +3.73% |
| Jun 3, 2026 | Mann Paul Elliot | Chairman and CEO | Sell | 83,759 | $7.76 | $650K | 9,579,845 | +5.56% | -8.59% |
| Jun 2, 2026 | Mann Paul Elliot | Chairman and CEO | Sell | 83,758 | $8.29 | $694K | 9,663,424 | +5.56% | -8.59% |
| Jun 1, 2026 | Mann Paul Elliot | Chairman and CEO | Sell | 83,758 | $7.88 | $660K | 9,747,182 | +5.56% | -8.59% |
8-K · 7.01
! Medium
ASP Isotopes Inc. -- 8-K 7.01: Regulation FD Disclosure
Sep 8
8-K · 1.01
!! High
ASP Isotopes Inc. -- 8-K 1.01: Material Agreement
Aug 20
8-K · 7.01
! Medium
ASP Isotopes Inc. -- 8-K 7.01: Regulation FD Disclosure
Aug 20
8-K · 7.01
! Medium
ASP Isotopes Inc. -- 8-K 7.01: Regulation FD Disclosure
Aug 18
8-K · 2.02
!! High
ENDRA Life Sciences Inc. -- 8-K 2.02: Earnings Results
Aug 17
8-K · 2.02
!! High
ASP Isotopes Inc. -- 8-K 2.02: Earnings Results
Aug 4
8-K · 7.01
! Medium
ASP Isotopes Inc. -- 8-K 7.01: Regulation FD Disclosure
Jul 30
8-K · 7.01
! Medium
ASP Isotopes Inc. -- 8-K 7.01: Regulation FD Disclosure
Jul 28
8-K · 7.01
! Medium
ASP Isotopes Inc. -- 8-K 7.01: Regulation FD Disclosure
Jul 21
8-K · 3.02
!! High
ASP Isotopes Inc. -- 8-K 3.02: Unregistered Securities Offering
Jul 16
8-K · 7.01
! Medium
ASP Isotopes Inc. -- 8-K 7.01: Regulation FD Disclosure
Jun 25
8-K · 7.01
! Medium
ENDRA Life Sciences Inc. -- 8-K 7.01: Regulation FD Disclosure
Jun 25
8-K · 7.01
! Medium
ASP Isotopes Inc. -- 8-K 7.01: Regulation FD Disclosure
Jun 23
8-K · 7.01
! Medium
ASP Isotopes Inc. -- 8-K 7.01: Regulation FD Disclosure
ASP Isotopes released an updated investor presentation on its website, providing shareholders with the latest company information and strategic updates.
May 26
NT 10-Q
!! High
ASP Isotopes Inc. -- Late Quarterly Report -- Distress Signal
May 15
8-K · 7.01
! Medium
ASP Isotopes Inc. -- 8-K 7.01: Regulation FD Disclosure
May 11
8-K · 7.01
! Medium
ASP Isotopes Inc. -- 8-K 7.01: Regulation FD Disclosure
ASP Isotopes appointed Fiske to the Strategic Advisory Board of Quantum Leap Energy LLC, potentially expanding expertise and industry connections to support the company's energy initiatives.
May 6
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
AspireOne released a press release with forward-looking statements, suggesting management communicated significant updates to investors; shareholders should review the full disclosure to assess potential impacts on future performance and valuation.
Apr 13
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
ASP Isotopes is hosting a business update call April 13, signaling management plans to discuss company developments; investors should listen for updates on critical materials production progress and strategic direction.
Apr 10
NT 10-K
!!! Very High
Unknown — Late Annual Report — Distress Signal
Late annual report filing signals potential financial or operational distress at Aspire Inc. (ASPI), raising delisting risk and warranting immediate investor caution on governance and compliance concerns.
Mar 31
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
ASP Isotopes' strategic collaboration on advanced laser research for lithium enrichment positions the company in high-demand critical materials, potentially unlocking significant revenue from energy and defense sectors.
Mar 24
8-K
Unknown — 8-K Filing
This boilerplate 8-K amendment suggests ASPI made minor corrections to an earlier disclosure without material changes, indicating no significant new business developments requiring investor attention.
Mar 24
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
ASP Isotopes completed critical Phase 1 drilling four months early, suggesting operational efficiency and accelerating commercialization timeline for its helium project, potentially derisking production and creating near-term catalysts.
Mar 23
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
ASP Isotopes' CEO participation in a sustainability summit suggests the company is positioning itself within the growing clean energy and critical materials sector, potentially signaling investor confidence and industry recognition that could attract ESG-focused capital.
Mar 10
8-K · 7.01
! Medium
ASP Isotopes Inc. -- 8-K 7.01: Regulation FD Disclosure
ASP Isotopes is evaluating U.S. government support for developing enriched uranium fuel supply capabilities, potentially positioning the company to benefit from domestic nuclear fuel production initiatives.
Mar 6
8-K · 7.01
! Medium
ASP Isotopes Inc. -- 8-K 7.01: Regulation FD Disclosure
ASP Isotopes disclosed material non-public information to select parties, requiring public dissemination to prevent unfair trading advantages and potentially signaling management confidence in undisclosed developments.
Mar 5
8-K · 7.01
! Medium
ASP Isotopes Inc. -- 8-K 7.01: Regulation FD Disclosure
ASP Isotopes signed an agreement with South Africa's Necsa to develop a uranium enrichment facility at Pelindaba, potentially positioning the company for revenue growth in nuclear fuel supply.
Feb 23
8-K · 7.01
! Medium
ASP Isotopes Inc. -- 8-K 7.01: Regulation FD Disclosure
ASP Isotopes disclosed material non-public information to select parties, potentially creating unequal market access and raising concerns about insider information handling that could trigger SEC scrutiny or litigation risk.
Feb 19
8-K · 7.01
! Medium
ASP Isotopes Inc. -- 8-K 7.01: Regulation FD Disclosure
ASP Isotopes disclosed material non-public information to select parties, requiring public disclosure under Regulation FD, which could indicate management communication about upcoming announcements affecting the stock's trading dynamics.
Feb 17
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 9,217,198 | $57M | New | Jun 2026 |
| 2 | Vanguard Capital Management Llc | 4,982,953 | $31M | Reduced | Jun 2026 |
| 3 | Encompass Capital Advisors Llc | 6,912,054 | $31M | New | Mar 2026 |
| 4 | Exchange Traded Concepts, Llc | 4,511,018 | $28M | New | Jun 2026 |
| 5 | Rovida Investment Management Ltd | 4,100,000 | $26M | — | Jun 2026 |
| 6 | Morgan Stanley | 3,419,566 | $18M | Added | Dec 2025 |
| 7 | Ubs Group Ag | 2,841,709 | $13M | Added | Mar 2026 |
| 8 | Alyeska Investment Group, L.p. | 2,692,166 | $12M | Reduced | Mar 2026 |
| 9 | Bnp Paribas Asset Management Holding S.a. | 1,577,016 | $10M | Added | Jun 2026 |
| 10 | Jane Street Group, Llc | 1,586,961 | $8M | Added | Dec 2025 |
| 11 | Vanguard Portfolio Management Llc | 1,115,391 | $7M | Added | Jun 2026 |
| 12 | Susquehanna International Group, Llp | 1,057,340 | $5M | Reduced | Mar 2026 |
| 13 | Barclays Plc | 1,012,956 | $4M | Added | Mar 2026 |
| 14 | Citadel Advisors Llc | 715,182 | $4M | Reduced | Jun 2026 |
| 15 | Northern Trust Corp | 937,523 | $4M | Added | Mar 2026 |
| 16 | Wim Investment Management Ltd | 541,400 | $3M | Reduced | Jun 2026 |
| 17 | Nuveen, Llc | 493,421 | $3M | Added | Jun 2026 |
| 18 | Philadelphia Financial Management Of San Francisco, Llc | 648,341 | $3M | New | Mar 2026 |
| 19 | Group One Trading Llc | 458,383 | $3M | New | Jun 2026 |
| 20 | Caprock Group, Llc | 321,365 | $2M | — | Jun 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$400.4M
Enterprise Value
$131.5M
P/E (TTM)
—
Forward P/E
—
PEG Ratio
-0.01x
P/B
1.00x
P/S
12.98x
P/FCF
-5.57x
EV/EBITDA
—
Shares Out
83.0M
Financials (TTM)
Revenue
$30.9M
Net Income
-$132.0M
EBITDA
-$129.2M
Free Cash Flow
-$47.4M
Op Cash Flow
-$37.8M
EPS Basic
$-2.11
EPS Diluted
$-1.32
EPS Forward
$-1.06
Gross Margin
18.3%
Op Margin
-312.3%
Net Margin
-428.0%
Balance Sheet
Total Assets
$512.9M
Total Liab.
$250.0M
Total Equity
$262.9M
Cash
$333.3M
LT Debt
$200.8M
Book Value/Sh
$3.17
Debt/Equity
1.06x
Current Ratio
12.18
Quick Ratio
11.92
Returns & Growth
ROE
-78.3%
ROA
-32.1%
ROIC
-11.6%
Rev Growth YoY
+475.5%
EPS Growth YoY
-234.9%
Price Returns
2W
-24.3%
1M
-20.5%
3M
-56.3%
6M
-24.6%
12M
-71.7%
Technicals
52W High
$14.49
52W Low
$3.04
50d MA
$3.94
200d MA
$5.40
RSI (14)
31.20
ATR (14)
$0.23
Beta
3.61
Avg Volume
3.7M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$13.00
High
$13.00
Low
$13.00
Median
$13.00
Data updated apr 24, 2026 7:17pm
· Source: financialmodelingprep.com